|

Liver Cancer Clinical Trials in San Francisco, CA

31 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)—<1 mi
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT TrialPhase 3<1 mi
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsPhase 1/2<1 mi
Radiation Therapy for the Treatment of Metastatic Gastrointestinal CancersN/A<1 mi
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsPhase 2<1 mi
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular CarcinomaPhase 1/2<1 mi
Checkpoint Inhibition In Pediatric Hepatocellular CarcinomaPhase 2<1 mi
National Liver Cancer Screening TrialPhase 4<1 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry—<1 mi
FOG-001 in Locally Advanced or Metastatic Solid TumorsPhase 1/2<1 mi
A Study of ZW251 in Participants With Advanced Solid TumorsPhase 1<1 mi
A Multicenter Cancer Biospecimen Collection Study—<1 mi
Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular CarcinomaPhase 2<1 mi
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway AberrationsPhase 1<1 mi
177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate CancerPhase 1<1 mi
Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)N/A<1 mi
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400Phase 1<1 mi
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine TumorsPhase 28 mi
Distance-Based Exercise to Preserve Function and Prevent DisabilityN/A8 mi
Observational Study Protocol: LIVER-R—21 mi
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRIN/A28 mi
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular CarcinomaPhase 328 mi
REGULUS: MRI-guided Adaptive SABR for Liver CancersPhase 228 mi
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology—28 mi
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid TumorsPhase 128 mi
Dose-defining Study of Tirapazamine Combined With Embolization in Liver CancerPhase 1/228 mi
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsPhase 1/228 mi
Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients—28 mi
Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90—28 mi
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid MalignanciesPhase 128 mi
The Vanguard Study: Testing a New Way to Screen for CancerN/A31 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.